18 November 2016 – Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, today announced that it has been recognized in Deloitte’s 2016 UK Fast 50 technology awards – securing the award in acknowledgment of the rapid growth achieved by the company over the course of the last four years. The accolade recognizes the success of Exco InTouch as the market leader in its field and pioneer of key innovations that have transformed the sector.
Central to the company’s growth strategy has been its commitment to improving lives for patients through utilizing technological advances to continuously enhance patient engagement, data capture and digital health solutions. Exco InTouch established the use of digital and mobile technology in clinical trials, including patient engagement services, eCOA (electronic Clinical Outcome Assessments) and ePRO (electronic Patient Reported Outcomes) capture.
The recent launch of the company’s Gather™ product suite – simplifying the clinical trial process for patients, investigative sites and pharmaceutical companies - is one of the key developments that Exco InTouch has brought to the field of mobile healthcare. Furthermore, its patented mDNA® technology, an automated management tool that seamlessly identifies, distributes and manages patients and their mobile device interactivity, enables the secure use of BYOD (bring your own device) approaches in both clinical research and healthcare programs.
Exco InTouch’s turnover is forecast to continue to grow significantly over the course of the next 12 months. Over 180 highly skilled personnel, with advanced expertise in mobile and digital technology, are employed across its international sites.
Tim Davis, CEO and Founder of Exco InTouch, commented: “We are delighted to have secured this accolade in recognition of the fact that we have emerged as one of the top 50 fastest growing technology companies in the UK. As the leader in our field, we look forward to continuing to drive technological innovation for both clinical trial and digital health programs. We will continue to bring the benefits of our robust and groundbreaking offerings to the benefit of patients and all key stakeholders to further improve health outcomes.”
He added: “The scope for sustained high growth for our company moving forwards is strong. This is as a result of the continued rapid expansion of the technological solutions market within the clinical and healthcare sectors and our firmly established partnerships with pharma companies in both the US and Europe.”
About Exco InTouch
Exco InTouch is the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers. Using a combination of software and services, Exco InTouch solutions provide simple, secure channels of communication; facilitating the collection of quality data and improving outcomes for sponsors, clinical research organizations, sites and patients.
Working across clinical and digital health programs, Exco InTouch’s flexible provisioning approach enables involvement which integrates into daily life - resulting in motivated and compliant patients, reducing costs associated with withdrawals from trials and improving overall program results.
Since 2004, Exco InTouch has engaged with over 1 million patients across 97 countries, over 32,000 hospitals and clinics, in 70 languages. 16 of the top 20 pharmaceutical companies have deployed our trusted applications in the knowledge that data is secure and protected, in line with global regulatory and data protection requirements.
About the Deloitte UK Fast 50
The UK Fast 50 is one of the UK's foremost technology awards programmes. Now in its nineteenth successful year, it is an acknowledgement of the 50 fastest-growing technology companies in the UK. The ranking is based on revenue growth over the last four years.
Launched in 1998, the awards acknowledge growth driven by leading intellectual property and are a celebration of innovation and entrepreneurship. The UK Fast 50 is part of an international programme run by Deloitte. Qualifying entrants of the UK Fast 50 will be put forward to the Deloitte Technology Fast 500 EMEA (Europe, Middle East and Africa) programme, along with entrants from other national programmes run by Deloitte in the EMEA region.
Previous winners have been both large and small companies. They include some of the most dynamic players in all areas of technology, ranging from internet specialists, digital media technology, computers, semiconductors, software, telecommunications and life science specialists.
For media enquiries, please contact Tristan Jervis or Alex Heeley on +44 (0) 207 203 6740 or e-mail: firstname.lastname@example.org
Last updated on: 18/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.